Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Indian Journal of Medical and Paediatric Oncology
Search Article 
  
Advanced search 
 
Year : 1995  |  Volume : 16  |  Issue : 1  |  Page : 21-24

Taxol : our experience.


P.D Hinduja National Hospital & Medical Research Centre, Bombay, India

Correspondence Address:
AC Kapadia
P.D Hinduja National Hospital & Medical Research Centre, Bombay, India

Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Taxol is one of the most important antineoplastic agents to emerge from drug screening over last decade. It has demonstrated its efficacy against ovarian, breast, lung as well as head and neck cancers, which are refractory to conventional, available chemotherapeutic agents. We have performed a pilot study with single agent Taxol in our patients with advanced, refractory stage of the disease(breast and lung cancer) to study and know more about the toxicity, efficacy and proper administration schedule. We have performed a pilot stdy with signle agent Taxol in our patients with advanced, refractory stage of the disease(breast and lung cancer) to study and know more about the toxicity, efficacy and proper administration schedule. We hope that, this knowledge gained out of our own experience will help in designing rational treatment regimens using Taxol as a single agent and in combinations.


[PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed643    
    Printed63    
    Emailed1    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal